NV
Nikesh Vadakke Veettil
About Nikesh Vadakke Veettil
Data last updated:
Nikesh Vadakke Veettil is a Director at Pharmia Bio Genesis Private Limited (since 2011), Director at Banrays Lens & Optics Private Limited (since 2016) and Director at Texa Biogenesis India Private Limited (since 2022). The companies operate in Trading, Home & Lifestyle and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹3.27 Cr; the largest is Pharmia Bio Genesis Private Limited at ₹3.23 Cr (FY 2025). Earlier, Nikesh Vadakke Veettil was a Director at Hann Biogenics Private Limited (2016–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharmia Bio Genesis Private Limited U24234KA2010PTC052066 | Director | 30 Sep 2011 | 2010 | ₹3.23 Cr (FY 2025) | Active |
| Banrays Lens & Optics Private Limited U33201KL2016PTC039888 | Director | 06 Feb 2016 | 2016 | ₹3.5 Lakh (FY 2025) | Active |
| Texa Biogenesis India Private Limited U24297KA2022PTC166991 | Director | 12 Oct 2022 | 2022 | ₹9,340 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Hann Biogenics Private Limited U51909KL2016PTC045871 | Director | 25 May 2016 | 2016 | ₹7 Lakh (FY 2022) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nikesh Vadakke Veettil
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikesh Vadakke Veettil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikesh Vadakke Veettil
Nikesh Vadakke Veettil currently holds 3 directorships: Pharmia Bio Genesis Private Limited (Director, since 30 Sep 2011, revenue ₹3.23 Cr (FY 2025)); Banrays Lens & Optics Private Limited (Director, since 06 Feb 2016, revenue ₹3.5 Lakh (FY 2025)); Texa Biogenesis India Private Limited (Director, since 12 Oct 2022, revenue ₹9,340 (FY 2025)).
Nikesh Vadakke Veettil was first appointed on 30 Sep 2011 as Director at Pharmia Bio Genesis Private Limited. The most recent appointment on record is 12 Oct 2022 at Texa Biogenesis India Private Limited.
The 3 current companies of Nikesh Vadakke Veettil that report revenue have a combined latest revenue of ₹3.27 Cr: Pharmia Bio Genesis Private Limited ₹3.23 Cr (FY 2025); Banrays Lens & Optics Private Limited ₹3.5 Lakh (FY 2025); Texa Biogenesis India Private Limited ₹9,340 (FY 2025).
Nikesh Vadakke Veettil held 1 earlier board appointment: Hann Biogenics Private Limited (Director, 25 May 2016 to 25 Jun 2018).
The current boards of Nikesh Vadakke Veettil's companies include Edappatta Murali (Pharmia Bio Genesis Private Limited), Illath Poyyil Vinod (Pharmia Bio Genesis Private Limited), Ramdas Thuppalle (Pharmia Bio Genesis Private Limited), Rameshkumar Thinakkal Kizahaparambil (Pharmia Bio Genesis Private Limited), Vinod Kumar Manchakandy (Pharmia Bio Genesis Private Limited), Athayi Mukesh (Banrays Lens & Optics Private Limited), among others.